Cargando…

Unintended target effect of anti-BCL-2 DNAi

INTRODUCTION: Previous research suggested that a novel compound PNT2258 inhibits B-cell lymphoma 2 (BCL-2) transcription by DNA interference (DNAi) and demonstrated its activity in preclinical xenograft models and in a pilot Phase II clinical trial in non-Hodgkin’s lymphoma (NHL). While the drug dow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ebrahim, Abdul Shukkur, Kandouz, Mustapha, Emara, Nada, Sugalski, Amara B, Lipovich, Leonard, Al-Katib, Ayad M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624602/ https://www.ncbi.nlm.nih.gov/pubmed/28989285 http://dx.doi.org/10.2147/CMAR.S139105

Ejemplares similares

Isolation and characterization of a CD34(+) sub-clone in B-cell lymphoma
por: Al-Katib, Ayad M., et al.
Publicado: (2020)

PNT2258, a novel deoxyribonucleic acid inhibitor, induces cell cycle arrest and apoptosis via a distinct mechanism of action: a new class of drug for non-Hodgkin's lymphoma
por: Ebrahim, Abdul Shukkur, et al.
Publicado: (2016)

Targeting CD19 in B-cell lymphoma: emerging role of SAR3419
por: Raufi, Ali, et al.
Publicado: (2013)

Spatio-temporal regulation of EGFR signaling by the Eps15 homology domain-containing protein 3 (EHD3)
por: Amessou, Mohamed, et al.
Publicado: (2016)

The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer
por: Ebrahim, Abdul Shukkur, et al.
Publicado: (2021)

Targeted Downregulation of MYC through G-quadruplex Stabilization by DNAi
por: Psaras, Alexandra Maria, et al.
Publicado: (2021)

A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
por: Tolcher, Anthony W., et al.
Publicado: (2013)

Modulation of deoxycytidine kinase (dCK) and glycogen synthase kinase (GSK-3β) by anti-CD20 (rituximab) and 2-chlorodeoxyadenosine (2-CdA) in human lymphoid malignancies
por: Al-Katib, Ayad M, et al.
Publicado: (2014)

Targeted testing for DNAI1 hot spot-mutation utilizing immunofluorescence microscopy findings
por: Szczepaniak, M, et al.
Publicado: (2012)

Shorter Cilia Length and Aberrant Ciliated Marker DNAI1 in Allergic Rhinitis
por: Zhou, Suizi, et al.
Publicado: (2023)

Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide
por: Rodrigueza, Wendi V., et al.
Publicado: (2014)

Population specificity of the DNAI1 gene mutation spectrum in primary ciliary dyskinesia (PCD)
por: Ziętkiewicz, Ewa, et al.
Publicado: (2010)

Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-X(L )and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model
por: Arnold, Alan A, et al.
Publicado: (2008)

CCDC114, DNAI2 and TOP2A involves in the effects of tibolone treatment on postmenopausal endometrium
por: Lv, Yanhua, et al.
Publicado: (2021)

A novel zinc-binding fold in the helicase interaction domain of the Bacillus subtilis DnaI helicase loader
por: Loscha, Karin V., et al.
Publicado: (2009)

Helicase binding to DnaI exposes a cryptic DNA-binding site during helicase loading in Bacillus subtilis
por: Ioannou, Charikleia, et al.
Publicado: (2006)

SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status
por: Al-Katib, Ayad M, et al.
Publicado: (2009)

New targets for the treatment of follicular lymphoma
por: Tageja, Nishant, et al.
Publicado: (2009)

A novel genetic variant in DNAI2 detected by custom gene panel in a newborn with Primary Ciliary Dyskinesia: case report
por: Rocca, Maria Santa, et al.
Publicado: (2020)

Coagulation and anticoagulation in COVID-19
por: Hadid, Tarik, et al.
Publicado: (2021)

Identification of a novel founder variant in DNAI2 cause primary ciliary dyskinesia in five consanguineous families derived from a single tribe descendant of Arabian Peninsula
por: Al-Mutairi, Dalal A., et al.
Publicado: (2022)

Lymphomatoid Granulomatosis in a Patient with Chronic Lymphocytic Leukemia and Rapidly Progressing Peribronchovascular Pulmonary Infiltrates
por: Rezvani, Shahab, et al.
Publicado: (2019)

Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy
por: Al‐Katib, Ayad M., et al.
Publicado: (2020)

miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery
por: Alam, Tanvir, et al.
Publicado: (2021)

Disulfiram—Mitigating Unintended Effects
por: Grout, Martha M., et al.
Publicado: (2023)

Syncytial giant cell hepatitis associated with chronic lymphocytic leukemia: a case report
por: Gupta, Eva, et al.
Publicado: (2012)

Comparative genomics comes of age
por: Lipovich, Leonard
Publicado: (2002)

Determinants of unintended pregnancies among currently married women in Uganda
por: Wasswa, Ronald, et al.
Publicado: (2020)

Unintended Bias and Unintended Consequences: Geographic Bias in the Plastic Surgery Residency Match
por: Nagarkar, Purushottam A., et al.
Publicado: (2022)

Unintended Sunburn: A Potential Target for Sun Protection Messages
por: McLeod, Geraldine F. H., et al.
Publicado: (2017)

Composite Lymphoma: Opposite Ends of Spectrum Meet
por: Khan, Uqba, et al.
Publicado: (2017)

Functional optimization of electric cell-substrate impedance sensing (ECIS) using human corneal epithelial cells
por: Ebrahim, Abdul Shukkur, et al.
Publicado: (2022)

Thrombotic thrombocytopenic purpura presenting as acute coronary syndrome
por: Mouabbi, Jason Aboudi, et al.
Publicado: (2016)

Unintended consequences of technology improvement
por: McGee, W, et al.
Publicado: (2010)

Unintended Consequences of not Specifying Exclusionary Illnesses for Systemic Exertion Intolerance Disease
por: Jason, Leonard A., et al.
Publicado: (2015)

Renewable energy targets and unintended storage cycling: Implications for energy modeling
por: Kittel, Martin, et al.
Publicado: (2022)

Unintended on-target chromosomal instability following CRISPR/Cas9 single gene targeting
por: Przewrocka, J., et al.
Publicado: (2020)

Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in Pseudomonas aeruginosa-Induced Keratitis
por: Wang, Yuxin, et al.
Publicado: (2021)

Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during Pseudomonas aeruginosa-Induced Corneal Infection
por: Wang, Yuxin, et al.
Publicado: (2021)

Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
por: Dupont, Thibault, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f9g9735nr4s0hifm1o2o81lajl